Fu Gang of Baiyang Medical Group Drives Digital Transformation Through 'Component Development + Solution Integration' Strategy
VCBeat (WeChat ID: vcbeat) has learned that the IDC Digital Economy Summit (DX Summit), themed “Digital Economy—Collaboration, Innovation, Acceleration,” was held in Singapore on October 25. At the event, Fu Gang, Chairman of Baiyang Pharmaceutical Group, was awarded the IDC Asia/Pacific Digital Transformation Leader Award (DX Leader) for his forward-looking explorations in the digital transformation of healthcare and medical services, as well as for integrating comprehensive solutions featuring world-class medical artificial intelligence and other innovative achievements. He is the only corporate leader from China to receive this prestigious honor.
IDC believes that digital transformation mainly involves five major aspects: leadership transformation, omnichannel experience transformation, information and data transformation, operational model transformation, and workforce resource transformation. These are also the key evaluation criteria for the "Digital Transformation Leader of the Year" award. Fu Gang has received authoritative recognition from IDC for his valuable explorations in medical digital transformation.
Fu Gang, Chairman of Baiyang Pharmaceutical Group, Won the “2018 China Digital Transformation Top 10 Figures of the Year” Award
Currently, a new round of technological revolution and industrial transformation is reshaping the global innovation landscape and restructuring the global economic framework. With the accelerated application of various IT innovations in offline scenarios, digital transformation will become the central theme for all enterprises over the next decade. As of 2017, more than 50% of China’s Top 1000 large enterprises had established digital transformation as their core corporate strategy.
According to IDC’s research, the global digital economy will reach $45 trillion in 2021, accounting for more than 50% of the total, while China’s digital economy will account for over 55%. Wu Lianfeng, Vice President and Chief Analyst at IDC China, stated, “Currently, 80% of enterprises worldwide regard digital transformation as their most critical strategy, and China has become the second-largest market for the digital economy globally.”
IDC believes that digital transformation of enterprises is the foundation of the digital economy, and business application scenarios are the cornerstone of enterprise digital transformation and innovation. In China, digital transformation in the financial and retail sectors has become relatively mature, while it is accelerating in industries such as manufacturing and healthcare.
In the medical field, as a leading domestic platform for innovative integration of health industry resources, Baiyang Pharmaceutical Group has taken the forefront in digital transformation and become a reference and model for future intelligent healthcare.
Regarding Fu Gang’s selection as a Leader in Digital Transformation, IDC stated: Under Fu Gang’s leadership, Baiyang has successfully developed a comprehensive suite of solutions in the field of smart healthcare. On one hand, Baiyang leverages emerging technologies such as big data, the Internet of Things (IoT), and artificial intelligence to drive reform in the healthcare industry. On the other hand, Baiyang integrates industrial resources with healthcare sector advantages to build a cloud platform ecosystem supported by the Baiyang Intelligent Research Institute as its technological backbone, and anchored by its AI-driven commercial marketing cloud (Mingjing Marketing Cloud) and intelligent healthcare cloud (Puti Healthcare Cloud). Through this “Two Clouds, One Institute” framework, Baiyang provides holistic smart healthcare application solutions for governments, medical institutions, enterprises, physicians, and patients.
Currently, China's healthcare industry is in a critical period of rapid transition from the foundational stage of informatization to the stage of innovative applications of medical big data. Driven by emerging technologies such as cloud computing, big data, and artificial intelligence, the healthcare sector is accelerating its digital transformation.
Fu Gang stated, “Digitalization is the prerequisite for intelligent healthcare. If an enterprise’s level of digitalization is insufficient, artificial intelligence cannot fully leverage its data processing capabilities. Therefore, it is impossible for a single company to independently complete the digital transformation process. Baiyang’s strategy is to partner with world-class enterprises for each key ‘component.’ To date, Baiyang has formed strong alliances with IBM, Oracle, and Philips, thereby building a more comprehensive overall solution.”
Leveraging its profound understanding of the healthcare industry, Baiyang Pharmaceutical Group capitalizes on the strengths of various “components” to build three integrated solutions encompassing smart hospitals, intelligent pharmacies, and digital marketing. By incorporating Watson for Oncology, Watson for Genomics, Philips’ AI-assisted imaging and pathology diagnostic systems, the Yifuzhen third-party prescription sharing platform, SPD intelligent supply chain solutions, Oracle ERP Cloud, and Marketing Cloud, the group provides comprehensive solutions across all segments of the healthcare and wellness industry, thereby empowering industrial transformation and upgrading.
In Fu Gang’s view, every step taken by Baiyang Pharmaceutical Group in accelerating the digital transformation of the healthcare industry is grounded in the sector’s genuine needs, thereby integrating scenario-based, systematic holistic solutions. Looking ahead, Baiyang will seize the opportunities of the era and leverage its comprehensive strengths in overall strategic layout, talent development, advantageous components, and specialized solutions to drive the digital transformation of China’s healthcare industry.